Oxford BioTherapeutics (OBT) has lined up another big pharma partner for its drug discovery platform, agreeing to work with ...
Pharmaceutical Technology on MSN1d
Oxford BioTherapeutics and Roche link on antibody cancer treatmentsOxford BioTherapeutics (OBT) has entered a multi-year partnership with Roche to discover antibody-based therapeutics for ...
Work to create a platform for Oxford rail station has been delayed by ongoing efforts to get Botley Road reopened. Network Rail closed Botley Road at the rail bridge as part of a £161m scheme to ...
Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback